Sarah Cannon Promotes Melissa Johnson, MD, to Program Director, Lung Cancer Research
Press release content from Business Wire. The AP news staff was not involved in its creation. Sarah Cannon Promotes Melissa Johnson, MD, to Program Director, Lung Cancer Research December 17, 2020 GMT NASHVILLE, Tenn.--(BUSINESS WIRE)--Dec 17, 2020-- Today, Sarah Cannon announced the promotion of Melissa Johnson, MD, to Program Director of Lung Cancer Research. In her new role, Dr. Johnson will lead the lung cancer clinical trial portfolio across the Sarah Cannon network. “Since joining Sarah Cannon, Dr. Johnson’s contributions to research have helped transform the treatment options avail...